Literature DB >> 11313753

Different types of repeat expansion in the TATA-binding protein gene are associated with a new form of inherited ataxia.

C Zühlke1, Y Hellenbroich, A Dalski, N Kononowa, J Hagenah, P Vieregge, O Riess, C Klein, E Schwinger.   

Abstract

A novel neurological syndrome has recently been described to be associated with an expanded polyglutamine domain. The expansion results from partial duplication within the TATA-binding protein (TBP). By investigation of 604 sporadic and familial cases with various forms of neurological syndromes and 157 unaffected individuals, we found repeat expansions in the TBP in four patients of two families with autosomal dominant inheritance of ataxia, dystonia, and intellectual decline. Two different genotypes for the repetitive sequence could be demonstrated which led to elongated polyglutamine stretches between 50 and 55 residues, whereas normal alleles with 27 to a maximum of 44 glutamine residues were found in this study. The expansion to 50 or more glutamine residues results in a pathological phenotype and confirms the report of a new polyglutamine disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313753     DOI: 10.1038/sj.ejhg.5200617

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  27 in total

Review 1.  Critical evaluation of in silico methods for prediction of coiled-coil domains in proteins.

Authors:  Chen Li; Catherine Ching Han Chang; Jeremy Nagel; Benjamin T Porebski; Morihiro Hayashida; Tatsuya Akutsu; Jiangning Song; Ashley M Buckle
Journal:  Brief Bioinform       Date:  2015-07-15       Impact factor: 11.622

Review 2.  Genetically modified rodent models of SCA17.

Authors:  Yiting Cui; Su Yang; Xiao-Jiang Li; Shihua Li
Journal:  J Neurosci Res       Date:  2016-11-18       Impact factor: 4.164

3.  Mutation at the SCA17 locus is not a common cause of primary dystonia.

Authors:  Kathrin Grundmann; Ulrike Laubis-Herrmann; Dirk Dressler; Juliane Vollmer-Haase; Peter Bauer; Manfred Stuhrmann; Thorsten Schulte; Ludger Schöls; Helge Topka; Olaf Riess
Journal:  J Neurol       Date:  2004-10       Impact factor: 4.849

Review 4.  Impact of nuclear organization and dynamics on epigenetic regulation in the central nervous system: implications for neurological disease states.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Ann N Y Acad Sci       Date:  2010-09       Impact factor: 5.691

Review 5.  The spinocerebellar ataxias: order emerges from chaos.

Authors:  Russell L Margolis
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

6.  From normal gait to loss of ambulation in 6 months: a novel presentation of SCA17.

Authors:  R Mehanna; I Itin
Journal:  Cerebellum       Date:  2013-08       Impact factor: 3.847

Review 7.  Spinocerebellar ataxia type 17 is caused by mutations in the TATA-box binding protein.

Authors:  Christine Zühlke; Katrin Bürk
Journal:  Cerebellum       Date:  2007-01-19       Impact factor: 3.847

8.  Polyglutamine expansion reduces the association of TATA-binding protein with DNA and induces DNA binding-independent neurotoxicity.

Authors:  Meyer J Friedman; Chuan-En Wang; Xiao-Jiang Li; Shihua Li
Journal:  J Biol Chem       Date:  2008-01-24       Impact factor: 5.157

9.  Transcriptional dysregulation of TrkA associates with neurodegeneration in spinocerebellar ataxia type 17.

Authors:  Anjali G Shah; Meyer J Friedman; Shanshan Huang; Meredith Roberts; Xiao-Jiang Li; Shihua Li
Journal:  Hum Mol Genet       Date:  2009-07-30       Impact factor: 6.150

10.  Spinocerebellar ataxia 17 (SCA17) and Huntington's disease-like 4 (HDL4).

Authors:  Giovanni Stevanin; Alexis Brice
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.